NCT02072863 A Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT02071888 Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors Status COMPLETED Phase PHASE1
NCT02064387 Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Clinical Activity of GSK2857916 Status COMPLETED Phase PHASE1
NCT02057640 MLN9708 (Ixazomib) in Combination With Panobinostat and Dexamethasone in Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT02056756 Carfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT02046070 Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma Status COMPLETED Phase PHASE2
NCT02045017 Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency Status COMPLETED Phase PHASE2
NCT02043860 Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma Status TERMINATED Phase PHASE1
NCT02036502 A Study of Pembrolizumab (MK-3475) in Combination With Standard of Care Treatments in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023) Status TERMINATED Phase PHASE1
NCT02035189 Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients Status COMPLETED Phase N/A
NCT02030483 Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma Status TERMINATED Phase PHASE1
NCT02011113 Japanese Phase 2 Study to Evaluate the Efficacy and Safety of Pomalidomide in Subjects With Relapsed and Refractory Multiple Myeloma Status COMPLETED Phase PHASE2
NCT02007811 Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination Status UNKNOWN Phase PHASE1/PHASE2
NCT02002598 Carfilzomib With Bendamustine and Dexamethasone in Multiple Myeloma Status TERMINATED Phase PHASE1/PHASE2
NCT01999335 A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refractory Multiple Myeloma Status TERMINATED Phase PHASE1